KATIE KUZMA: Open Payments
NPI 1851945257 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,328 in 51 payments from 16 companies in 2025. Trend: 2023 $370 · 2024 $397 · 2025 $1,328
Food & beverage: $1,328
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $193 |
| AstraZeneca Pharmaceuticals LP | 4 | $173 |
| ABBVIE INC. | 14 | $161 |
| AngioDynamics, Inc. | 1 | $161 |
| ARGENX US, INC. | 1 | $124 |
| Axsome Therapeutics, Inc. | 1 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $81 |
| Amgen Inc. | 4 | $64 |
| GlaxoSmithKline, LLC. | 2 | $47 |
Products named: AURYON LASER SYSTEM 100-120 VAC, AIRSUPRA, Ozempic, VYVGART, Auvelity, VRAYLAR, CAPLYTA, Kerendia.
Industry payments across KY — which companies pay providers there.
